Archives of Gynecology and Obstetrics

, Volume 299, Issue 1, pp 217–222 | Cite as

The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?

  • Ali Ayhan
  • Huseyin AkilliEmail author
  • Nihan Haberal
Gynecologic Oncology



The aim of this study was to determine the clinicopathologic features and the prognostic significance of Stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts.

Materials and methods

Patients with either Stage I ovarian clear cell or endometrioid carcinoma were divided into three groups. *Group 1: Patients with cancers arising from endometriotic cysts *Group 2: Patients with ovarian and pelvic endometriosis *Group 3: Patients without endometriosis Patient characteristics (overall survival and disease-free survival) were compared between groups.


Of the 78 patients who participated in this study, 39 were in group 1, 13 were in group 2, and 26 were in group 3. The mean age in groups 1, 2, and 3 were 46 years, 54 years, and 48 years, respectively (p = 0.39). Tumoral characteristics, including capsule rupture, positive cytology, grade, and the presence of synchronous endometrial cancer were similar in both groups. The 5-year overall survival rate in groups 1, 2, and 3 were 100, 90, and 93%, respectively (p = 0.4). Moreover, the recurrence rates did not differ significantly between groups. Furthermore, subgroup analysis of clear cell carcinoma and endometrioid adenocarcinoma separately showed no effect of endometriosis on disease-free survival (DFS) or overall survival (OS).


Clear cell or endometrioid ovarian carcinoma arising from ovarian and/or pelvic endometriosis shares the same clinicopathologic characteristics with their counterparts that do not arise from endometriosis and patients have similar overall and disease-free survival.


Endometriotic cyst Stage I EOC Prognosis Gynecologic oncology 


Author contributions

AA: project development, data collection and management, data analysis, manuscript writing, and editing. HA: project development, data collection, manuscript writing, and literature search. NH: data analysis and editing.

Compliance with ethical standards

Conflict of interest

The authors declare there are no conflicts of interest—financial or otherwise—related to the material presented herein.

Ethics approval

Ethical approval for the present study was not required, as it was retrospectively performed.


  1. 1.
    Redwine DB (1999) Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease. Fertil Steril 72(2):310–315CrossRefGoogle Scholar
  2. 2.
    Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T et al (2007) Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 17(1):37–43CrossRefGoogle Scholar
  3. 3.
    Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K et al (2000) Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 77(2):298–304CrossRefGoogle Scholar
  4. 4.
    Melin A, Sparen P, Persson I, Bergqvist A (2006) Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 21(5):1237–1242CrossRefGoogle Scholar
  5. 5.
    Kondi-Pafiti A, Papakonstantinou E, Iavazzo C, Grigoriadis C, Salakos N, Gregoriou O (2012) Clinicopathological characteristics of ovarian carcinomas associated with endometriosis. Arch Gynecol Obstet 285(2):479–483CrossRefGoogle Scholar
  6. 6.
    Qiu L, Wang S, Lang JH, Shen K, Huang HF, Pan LY et al (2013) The occurrence of endometriosis with ovarian carcinomas is not purely coincidental. Eur J Obstet Gynecol Reprod Biol 170(1):225–228CrossRefGoogle Scholar
  7. 7.
    Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE et al (2004) Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 82(2):405–414CrossRefGoogle Scholar
  8. 8.
    Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13(4):385–394CrossRefGoogle Scholar
  9. 9.
    Van Gorp T, Amant F, Neven P, Vergote I, Moerman P (2004) Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 18(2):349–371CrossRefGoogle Scholar
  10. 10.
    Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF (2008) Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol 110(3):336–344CrossRefGoogle Scholar
  11. 11.
    Kumar S, Munkarah A, Arabi H, Bandyopadhyay S, Semaan A, Hayek K et al (2011) Prognostic analysis of ovarian cancer associated with endometriosis. Am J Obstet Gynecol 204(1):63 e1–63 e7CrossRefGoogle Scholar
  12. 12.
    Cuff J, Longacre TA (2012) Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type. Am J Surg Pathol 36(5):688–695CrossRefGoogle Scholar
  13. 13.
    Wang S, Qiu L, Lang JH, Shen K, Huang HF, Pan LY et al (2013) Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. Am J Obstet Gynecol 209(3):241 e1–241 e9CrossRefGoogle Scholar
  14. 14.
    Kim HS, Kim TH, Chung HH, Song YS (2014) Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer 110(7):1878–1890CrossRefGoogle Scholar
  15. 15.
    Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G et al (2014) Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol 133(3):480–484CrossRefGoogle Scholar
  16. 16.
    Melin A, Lundholm C, Malki N, Swahn ML, Sparen P, Bergqvist A (2011) Endometriosis as a prognostic factor for cancer survival. Int J Cancer 129(4):948–955CrossRefGoogle Scholar
  17. 17.
    Ali-Fehmi R, Khalifeh I, Bandyopadhyay S, Lawrence WD, Silva E, Liao D et al (2006) Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis. Int J Gynecol Pathol 25(3):223–229CrossRefGoogle Scholar
  18. 18.
    Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H et al (2012) Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer 22(8):1310–1315CrossRefGoogle Scholar
  19. 19.
    Mangili G, Bergamini A, Taccagni G, Gentile C, Panina P, Vigano P et al (2012) Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience. Gynecol Oncol 126(3):403–407CrossRefGoogle Scholar
  20. 20.
    Munksgaard PS, Blaakaer J (2012) The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 124(1):164–169CrossRefGoogle Scholar
  21. 21.
    Ye S, Yang J, You Y et al (2014) Comparative study of ovarian clear cell carcinoma with and without endometriosis in People’s Republic of China. Fertil Steril 102:1656Y1662CrossRefGoogle Scholar
  22. 22.
    Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT et al (2018) Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer 28(1):11–18CrossRefGoogle Scholar
  23. 23.
    Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK (2002) Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol 100(4):788–795PubMedPubMedCentralGoogle Scholar
  24. 24.
    Schnack TH, Hogdall E, Thomsen LN, Hogdall C (2017) Demographic, clinical, and prognostic factors of ovarian clear cell adenocarcinomas according to endometriosis status. Int J Gynecol Cancer 27(9):1804–1812CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gynecology and ObstetricsBaskent University School of MedicineAnkaraTurkey
  2. 2.Baskent University School of MedicineAnkaraTurkey
  3. 3.Department of PathologyBaskent University School of MedicineAnkaraTurkey

Personalised recommendations